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Summary
The streptococcal antigen I/II (AgI/II)-family polypep-
tides are cell wall-anchored adhesins expressed by
most indigenous oral streptococci. Proteins sharing
30–40% overall amino acid sequence similarities with
AgI/II-family proteins are also expressed by Strepto-
coccus pyogenes. The S. pyogenes M28_Spy1325
polypeptide (designated AspA) displays an AgI/II
primary structure, with alanine-rich (A) and proline-
rich (P) repeats ﬂanking a V region that is projected
distal from the cell. In this study it is shown that AspA
from serotype M28 S. pyogenes, when expressed on
surrogate host Lactococcus lactis, confers binding to
immobilized salivary agglutinin gp-340. This binding
was blocked by antibodies to the AspA-VP region. In
contrast, the N-terminal region of AspA was deﬁcient
in binding ﬂuid-phase gp-340, and L. lactis cells
expressing AspA were not agglutinated by gp-340.
Deletion of the aspA gene from two different M28
strains of S. pyogenes abrogated their abilities to
form bioﬁlms on saliva-coated surfaces. In each
mutant strain, bioﬁlm formation was restored by trans
complementation of the aspA deletion. In addition,
expression of AspA protein on the surface of L. lactis
conferred bioﬁlm-forming ability. Taken collectively,
the results provide evidence that AspA is a bioﬁlm-
associated adhesin that may function in host coloni-
zation by S. pyogenes.
Introduction
Streptococcus pyogenes (groupAStreptococcus; GAS) is
a causative agent of tonsillitis, pharyngitis, otitis media,
impetigo, scarlet fever, cellulitis and necrotizing fasciitis.
The species is part of a phenotypically heterogeneous
group of bacteria that readily colonize humans and
animals, ordinarily forming part of the commensal micro-
biota (Nobbs et al., 2009). Under appropriate conditions,
S. pyogenes can cause opportunistic invasive infections
withhigh(10–35%)mortalityrates(NCIRD,2008).Inorder
to colonize, proliferate and persist, S. pyogenes must in
the ﬁrst instance adhere to host tissues. Numerous cell
wall-anchoredproteinshavebeenidentiﬁedonthesurface
of S. pyogenes (Nobbs et al., 2009) that mediate adher-
ence to host tissue proteins such as ﬁbronectin (Cue et al.,
2001), ﬁbrinogen (Hryniewicz et al., 1972; Courtney et al.,
2002), albumin (Schmidt et al., 1993), immunoglobulins
(Fagan et al., 2001; Okamoto et al., 2008) and mucin
(Ryan et al., 2001). However, the mechanisms by which
S. pyogenes colonizes oral or nasopharyngeal surfaces
are not fully understood.
Streptococcus pyogenes has the potential to form bio-
ﬁlms in the oral cavity and nasopharynx (Doern et al.,
2009), and on skin and wounds. Cases of pharyngitis from
which bioﬁlm-forming S. pyogenes have been isolated
have been associated with multiple episodes of disease
and 30% treatment failure (Lembke et al., 2006). It is clear
that the ability of S. pyogenes to form bioﬁlms varies
considerably with respect to serotype and strain (Lembke
et al., 2006; Courtney et al., 2009). One of the mecha-
nisms proposed for initial adherence and accumulation of
M1 serotype S. pyogenes involves the formation of com-
plexes between cell surface lipoteichoic acid (LTA) and
members of the M protein family (Courtney et al., 2009).
Another more recent ﬁnding is that pilus structures (Mora
et al., 2005) are involved in development of bioﬁlm aggre-
gates (Manetti et al., 2007; Koller et al., 2009). Clearly
GAS utilizes different complements of surface proteins to
adhere to host tissues and form bioﬁlms.
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family of cell surface proteins plays many roles in coloni-
zation of the host. The AgI/II-family polypeptides are cell
wall-anchored and comprise between 1310 and 1653
amino acid (aa) residues (Brady et al., 2010). The SpaP
(AgI/II-family) protein in Streptococcus mutans mediates
adherence to salivary glycoproteins within the tooth
enamel pellicle (Bowen et al., 1991). Antibodies to SpaP
block adherence of S. mutans (Munro et al., 1993), and a
peptide vaccine derived from SpaP has been shown to
protect rodents against dental decay caused by S. mutans
(Takahashiet al.,1991).Otherindigenousstreptococci,for
example Streptococcus gordonii, express two AgI/II pro-
teins, designated SspA and SspB, from duplicated genes
(Jakubovics et al., 2005). The SpaP, SspA and SspB pro-
teins have a common host receptor in gp-340, a member
of the scavenger receptor cysteine-rich (SRCR) protein
family(Madsenet al.,2010).Gp-340isamucin-likeprotein
found in saliva, tears, and at mucosal surfaces. It functions
in innate immune defence, complexing with other mucosal
components such as mucins, collectins (Ligtenberg et al.,
2007) and secretory immunoglobulinA(S-IgA) (Ligtenberg
et al., 2004), and trapping microbes for removal from the
body (Ligtenberg et al., 2007). However, when gp-340
becomes adsorbed to a surface, such as within salivary
pellicle, gp-340 acts as a receptor for microbial adherence
(Loimaranta et al., 2005). Additionally, AgI/II-family pro-
teins have been shown to bind ﬁbronectin (Nobbs et al.,
2007), collagen (Soell et al., 2010), the oral bacteria Acti-
nomyces naeslundii (Jakubovics et al., 2005) and Porphy-
romonas gingivalis (Daep et al., 2008), and the yeast
Candida albicans (Silverman et al., 2010). These proteins
therefore play potentially multiple roles in Streptococcus
adherence, colonization and microbial community devel-
opment.
Epidemiological studies of GAS associated with puer-
peralsepsis,amajorcauseofdeathofyoungwomeninthe
past, have identiﬁed serotype M28 strains as being largely
responsible. The genome sequences of a series of M28
invasive strains revealed that they had all acquired a
37.4 kb element, shared with group B Streptococcus
(GBS), designated region of difference 2 (RD2). This
region contained genes encoding prophage virulence
factors, R-28 surface protein antigen (Johnson, 1975;
Stålhammar-Carlemalm et al., 1999) and six other inferred
secreted proteins (Green et al., 2005). One of these genes
encoded a protein (designated M28_Spy1325) with
structural and sequence similarities to oral streptococcal
AgI/II-family proteins (Fig. 1) (Jenkinson and Demuth,
1997). Preliminary characterization of the S. pyogenes
AgI/II protein M28_Spy1325 (predicted molecular mass
148.36 kDa) indicated that it interacted with gp-340 in a
manner consistent with that of other AgI/II-family proteins
(Zhang et al., 2006). In addition, bioinformatic analyses
revealed common ancestral characteristics of M28_
Spy1325(denotedAspAforgroupAStreptococcussurface
protein A) that placed it ﬁrmly within the AgI/II-family of
streptococcalproteins.LossofsectionsoftheN-terminalA
and V regions has resulted in AspA being slightly smaller
than many of the other oral streptococcal AgI/II proteins
(Fig. S1) (Brady et al., 2010).
Although AspA binds gp-340 (Zhang et al., 2006), the
primary structural differences between AspA and SspB
suggested a differential role forAspAmay have evolved in
pathogenic GAS. To test this hypothesis we investigated
the structural and functional properties of AspA in more
detail, particularly in respect to binding gp-340 and in
bioﬁlm community development. We show that AspA
expressed on the surrogate host Lactococcus lactis binds
immobilized gp-340, but the N-terminal region is defective
in interaction with ﬂuid-phase gp-340. In addition, expres-
sion of AspA appears to be essential for bioﬁlm formation
by two independently isolated M28 serotype strains of
S. pyogenes. It is suggested that expression of AspA may
confer on GAS the ability to successfully compete with
indigenous commensal streptococci in colonizing host
surfaces while avoiding, at least in part, host innate
immune pressures.
Results
Primary sequence differences between AspA and SspB
The AgI/II-family polypeptides have a common NAVPC
region structure (Fig. 1), as described above, with highest
Fig. 1. Pictorial representation of AgI/II proteins of (A) S. pyogenes serotype M28 (strain MGAS6180) and (B) S. gordonii DL1, showing the
recombinant fragments generated in this study. Included are the aa residue numbers demarcating each of the protein fragments. Structural
features are as follows: LS, leader sequence; N, N-terminal domain; A, alanine-rich repeats; V, variable region; P, proline-rich repeats;
C, C-terminal domain; and CW, cell wall anchor.
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region (Jenkinson and Demuth, 1997). TheAla-rich repeat
(A) and Pro-rich repeat (P) regions also show various
degrees of sequence conservation across the family,
related to maintaining the N-terminal a-helix and C-
terminal polyproline helix structures, which together gen-
erate a stalk projecting the V region distal from the cell
surface-anchorage point (Brady et al., 2010; Larson et al.,
2010). The GAS AgI/II polypeptide A and P regions show
approximately 28% and 30% aa sequence identities,
respectively, to the A and P regions of SspB from
S. gordonii (see Fig. S1 for aa sequence alignments). The
C regions ofAspAand SspB have 38% aa residue identity,
while the V region sequences appear to be unrelated
(< 10% identical aa residues) (Fig. S1).
Antigenic differences between AspA and SspB
Previous studies have investigated the binding properties
of regions of AgI/II-family proteins by expressing recom-
binant fragments in Escherichia coli (Crowley et al., 1993;
Hajishengallis et al., 1994). These studies have been
paramount in deducing the 3D structure of AgI/II proteins
(Forsgren et al., 2009; 2010; Brady et al., 2010; Larson
et al., 2010). We have previously produced recombinant
fragments of S. gordonii SspB and shown that these puri-
ﬁed fragments have various binding activities with gp-340
(Nobbs et al., 2007). To compare therefore the binding
properties of AspA regions with corresponding regions of
SspB, we generated two sets of recombinant polypep-
tides (Fig. 1). The AspA polypeptides generated (Fig. 1A)
were, as far as possible, analogous to those that had
already been derived from SspB (Fig. 1B), except that we
were unable to express a stable VPC fragment fromAspA
(see Fig. 1A).
Since the aa sequence of the V region of AspA was
unique, we utilized fragment VP-AspA (Fig. 1A) to gener-
ate AspA-speciﬁc polyclonal antibodies. The reactivity of
these antibodies with AspA or SspB protein fragments
was compared with the reactivity of a polyclonal antibody
raised to SpaP from S. mutans (Jakubovics et al., 2005).
Anti-AspA-VP antibodies reacted as anticipated with
the homologous antigen, recombinant VP (rVP-AspA)
polypeptide (Fig. 2), but not with rNAV-SspB polypeptide
(Fig. 2) or with rNAVPC-SspB (not shown). The anti-SpaP
antibodies reacted with rNAV-SspB (Fig. 2) and with all of
the recombinant SspB polypeptides i.e. rNAVPC, rVPC
and rC (not shown). These observations were consistent
with the relatively well-conserved sequences across the
entire lengths of the SpaP and SspB proteins, with the
exception of the V regions (Brady et al., 2010). Con-
versely, the SpaP antibodies did not react with any of the
AspA recombinant polypeptides, reﬂecting the lower
aa sequence identities between AspA and SspB, and
suggesting major antigenic distinctions between the
two polypeptides.
Metal ion binding associated with V region
Within the V region aa sequence of AspA there is a His/
Asp motif, HDDWVHDTH (608–616 aa), which is not
annotated in any protein databases, and that is found only
in the AgI/II-family proteins identiﬁed in GAS and GBS. It
is known that clustered His residues form a region of high
electron density to which positively charged metal ions
may bind. Accordingly, inductively coupled plasma optical
emission spectrometry (ICP-OES) was utilized to deter-
mine trace metal ion binding to the rNAV polypeptides.
The analyses found that Zn2+ ions bound to rNAV-AspA at
a metal ion : protein ratio of approximately 1:1 (Fig. 3).
However, ICP-OES analysis of rNAV-SspB, which does
not contain the HD cluster, suggested that this region did
not speciﬁcally bind Zn2+ ions over and above similar
amounts of residual Fe2+ and Ni2+ associated with the
protein (Fig. 3). In addition, Mg2+ (or Ca2+) was found to be
associated with both AspA and SspB polypeptides at
metal ion : protein ratios of approximately 2:1 and 1:1
respectively (Fig. 3). Under the ICP-OES conditions used,
it was not possible to distinguish between Mg2+ and Ca2+.
Fig. 2. Western blots of recombinant protein fragments VP-AspA and NAV-SspB probed using anti-VP-AspA or anti-SpaP antibodies.
Equivalent amounts of protein (100 ng) as determined by Bradford assay were applied to each lane. Proteins were also stained with
Coomassie blue as a protein loading control.
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associated with the AgI/II-family protein V regions. The
residual amounts of Ni2+ present in both protein prepara-
tions (Fig. 3) may have arisen from the Ni2+ affinity column
utilized to purify the His-tagged polypeptides.
Interactions of ﬂuid-phase gp-340 with AspA fragments
By utilizing the recombinant polypeptides described in
Fig. 1, we then determined in far-Western blot overlays
withgp-340whichofthevariousrecombinantpolypeptides
were able to interact with gp-340. In these experiments,
binding of gp-340 to the blotted polypeptides was deter-
mined using monoclonal antibody to gp-340 polypeptide
backbone and anti-mouse HRP-conjugated secondary
antibody.AlloftheSspBfragments,i.e.rNAV,rVPCandrC,
and full-length rSspB, were found to bind gp-340 (Fig. 4).
Puriﬁed full-length rSspB was subject to degradation and
tended to bind gp-340 rather weakly. In contrast, only
the full-length rAspA and rC-AspA polypeptides bound
ﬂuid-phase gp-340, while the rNAV-AspA and rVP-AspA
polypeptides did not (Fig. 4). There were some apparent
discrepancies between predicted and observed molecular
masses on SDS-PAGE for some of these polypeptides.
Anomalous migration on SDS-PAGE is common for
polypeptides that are largely a-helical, e.g. A region, or
that contain regions of random coils, e.g. P region. The
C regions, on the other hand, resolved with predicted
molecular mass of approximately 55 kDa (Fig. 4).
Binding of L. lactis expressing AspA to immobilized
gp-340
The structurally conserved A, P and C regions of AgI/II-
family proteins are present in AspA and SspB, and
sequences within these three regions in SspB have all
been shown to interact with gp-340 (Brady et al., 2010).
To determine the ability of AspA to bind immobilized
gp-340, we cloned the aspA gene, and separately the
sspB gene, into the expression vector pKS80 (Hartford
et al., 2001) that replicates in L. lactis. The abilities of
L. lactis MG1363 strains expressing AspA (pKS80 aspA +)
or SspB (pKS80 sspB +) to adhere to gp-340 were com-
pared with control L. lactis MG1363 containing empty
vector, utilizing a crystal violet spectrophotometric assay.
Binding levels of L. lactis expressing AspA to immobilized
gp-340 were found to be similar to those of L. lactis
expressing SspB (Fig. 5A), while the control cells showed
< 5% binding of the protein-expressing strains.
Although only the C-terminal fragment of AspA bound
ﬂuid-phase gp-340 on far-Western blot overlays, it is
known that ﬂuid-phase gp-340 presents different recep-
tor conformations compared with immobilized gp-340
(Loimaranta et al., 2005). Accordingly, to determine if the
VP region of AspA carried sequences recognizing immo-
bilized gp-340, we investigated the effects of rVP-AspA
antibodies on adherence of L. lactis (pKS80 aspA +)t o
immobilized gp-340. It was found that antiserum raised to
rVP-AspA inhibited adherence of L. lactis (pKS80 aspA +)
cells to gp-340 in a dose-dependent manner (Fig. 5B),
whereas corresponding dilutions of antiserum raised to
S. mutans SpaP, which does not react with AspA (Fig. 2),
had no inhibitory effects (Fig. 5B). Antiserum against rVP-
AspA had no signiﬁcant inhibitory effect on adherence of
L. lactis (pKS80 sspB +) to immobilized gp-340 (data not
shown).
Aggregation properties of L. lactis cells expressing AspA
To then test the ability of AspA to mediate aggregation of
L. lactis by gp-340, aggregation of lactococcal suspen-
Fig. 3. Metal ion analysis of recombinant
protein fragments NAV-AspA (dark grey bars)
and NAV-SspB (light grey bars) by ICP-OES
using ICP multi-element standard solution IV
(Merck) and 100 ng ml
-1 protein. Values are
metal ion : protein ratios comparative to a
buffer standard containing no protein. Error
bars represent  SD from three independent
experiments. *P < 0.001 between samples as
indicated.
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also performed with a peptide, designated SRCR Peptide
2 (SRCRP2), in place of gp-340. This peptide comprises a
16-aa-residue sequence found within the SRCR domains
of the backbone of gp-340 (Leito et al., 2008). The peptide
is reported to be active in aggregating a wide range of
bacteria and it also interacts with AgI/II-family proteins
(Jakubovics et al., 2005). In aggregation assays with
gp-340, it was found that L. lactis cells expressing SspB
were strongly aggregated in the presence of gp-340 while
L. lactis cells expressing AspA were only weakly aggre-
gated (Fig. 6). On the other hand, L. lactis cells express-
ing AspA or SspB were aggregated equally well in the
presence of SRCRP2 (Fig. 6). These results indicate that
the overall mechanism involved in cell aggregation as
mediated by SRCRP2 is different from the mechanism
associated with gp-340-mediated cell aggregation. More-
over, these gp-340-mediated aggregation data are in
keeping with the above experimental results showing that
the N-terminal region of AspA did not bind ﬂuid-phase
gp-340 (Fig. 4). Although the C regions of AspA and SspB
were both shown to bind ﬂuid-phase gp-340 (Fig. 4),
clearly this interaction alone is not sufficient to promote
aggregation of L. lactis (pKS80 aspA +) cells by gp-340.
An additional property of SspB polypeptide is that
it mediates co-aggregation between S. gordonii and
A. naeslundii (Jakubovics et al., 2005). When expressed
on the surface of L. lactis, SspB confers the ability
on L. lactis to co-aggregate with A. naeslundii T14V
(renamed A. oris T14V). In a similar manner, SspA from
Fig. 4. Binding of ﬂuid-phase gp-340 by recombinant AspA or SspB protein fragments. SDS-PAGE patterns of proteins stained with
Coomassie blue (left-side panels) and corresponding far-Western blots of (A) AspA-recombinant proteins AspA (NAVPC), NAV, VP and C, and
(B) SspB-recombinant proteins SspB (NAVPC), NAV, VPC and C. Recombinant proteins (100–200 ng) were resolved by SDS-PAGE, blotted
onto nitrocellulose and overlayered with 100 ng gp-340 ml
-1. Binding of gp-340 to the bands was detected by probing with mouse monoclonal
gp-340 antibody followed by HRP-conjugated goat anti-mouse antibody.
1038 S. E. Maddocks etal. 
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with A. naeslundii PK606 but not with strain T14V
(Jakubovics et al., 2005). L. lactis expressing AspA
showed no co-aggregation ability with six different Actino-
myces strains, including T14V and PK606 (data not
shown). It is concluded that AspA does not interact with
A. naeslundii, a major bacterial component of early dental
plaque and of other oral bioﬁlm communities (Palmer
et al., 2003).
Role of AspA in GAS bioﬁlm formation
Since variousAgI/II-family adhesins have been implicated
in mediating adherence and bioﬁlm formation (Pecharki
et al., 2005; Ahn et al., 2008), we investigated the abilities
of two serotype M28 strains of S. pyogenes, MGAS6180
and H360, to form bioﬁlms on salivary pellicle. Knockout
mutants of these strains were generated as described in
Experimental procedures and were then complemented in
trans (see Fig. S2A). The allelic replacement resulted in
deletion of the complete coding sequence, leaving in
place the native promoter and terminator, as conﬁrmed by
sequencing. Moreover, sequencing determined that the
deduced aa sequence of AspA from strain H360 was
identical to that from MGAS6180.
To conﬁrm that the aspA gene was inactivated, cell wall
proteins were extracted from strains MGAS6180 and
H360 following incubation with mutanolysin/lysozyme,
separated by SDS-PAGE, and Western blots of proteins
were incubated with rVP-AspA antibodies. The AspA
protein in wild-type strain extracts appeared as a single
immunoreactive band (Fig. S2B), and this band was
absent from extracts of strains MGAS6180 DaspA and
H360 DaspA. Cell wall extracts of complemented strains
MGAS6180 DaspA (pKS80 aspA +) and H360 DaspA
(pKS80 aspA +) both showed presence of many-fold
higher levels of AspA protein than respective wild-type
strains (Fig. S2B).
The DaspA mutant strains of MGAS6180 and H360
were identical in colony morphology to the respective
parent strains, and had similar growth rates in minimal C
medium to the parent strains. In adherence assays to
immobilized gp-340, the mutants did not show any signiﬁ-
Fig. 5. Interactions of L. lactis strains expressing AspA or SspB
with immobilized gp-340 (50 ng).
A. Binding of L. lactis MG1363 (pKS80) control cells, L. lactis
(pKS80 sspB
+) and L. lactis (pKS80 aspA
+). Data represent the
average  SD of three independent experiments with triplicate
samples. **P < 0.005 relative to L. lactis pKS80.
B. Effect of dilutions of SpaP antiserum (grey ﬁll) or rVP-AspA
antiserum (black ﬁll) on adherence of L. lactis (pKS80 aspA
+) cells
to gp-340. Control indicates no antiserum added. Input cell
numbers in all experiments were 5 ¥ 10
7 cells well
-1. Error bars
are  SD of two independent experiments with duplicate samples.
**P < 0.005, *P < 0.05, relative to no antiserum control.
Fig. 6. Aggregation of L. lactis strains expressing AspA or SspB in
the presence of gp-340 or SRCRP2 peptide. Cells (10
8 cells ml
-1)
of each strain were incubated with 100 ng ml
-1 gp-340 or 100 ng
ml
-1 SRCRP2 peptide, or in PBS alone, at 37°C for up to 5 h.
Optical density (600 nm) was measured at intervals over 5 h and %
aggregation was calculated from change in OD600, corrected for
OD600 decrease in controls. Columns are L. lactis MG1363 (open),
L. lactis (pKS80 aspA+) (grey ﬁll) and L. lactis (pKS80 sspB+)
(black ﬁll). The data represent the average  SD of three
independent experiments with triplicate samples. **P < 0.005,
*P < 0.05, relative to respective buffer only controls.
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respective wild-type (results not shown). This phenotype
was not unexpected since at least two other proteins on
the surface of GAS are known to interact with gp-340
(Edwards et al., 2008; Loimaranta et al., 2009).
Confocal laser scanning microscopy (CLSM) was
employed to investigate differences in the development
and structure of S. pyogenes bioﬁlms as a consequence
of deleting aspA. Wild-type strain MGAS6180 formed a
bioﬁlm after 24 h that was about 25 mm thick, consisting
of densely packed cells with very little of the underlying
salivary pellicle substratum visible (Fig. 7A). The corre-
sponding knockout mutant, MGAS6180 DaspA, showed
a much reduced bioﬁlm thickness, with areas of the pel-
Fig. 7. Confocal laser scanning microscopy
images and biomass measurements of 24 h
bioﬁlms formed on salivary pellicle-coated
coverslips, comparing bioﬁlm structures of (A)
S. pyogenes MGAS6180 and (B) strain H360,
and corresponding isogenic DaspA mutants
and complemented strains DaspA (aspA
+).
Biomass data were obtained by crystal violet
assay (A595) of corresponding bioﬁlms formed
on coverslips. One unit is equivalent to the
grid square side length. Data are averages 
SD of three independent experiments.
**P < 0.005 relative to MGAS6180 (A) or
H360 (B) wild-type strains.
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© 2011 Blackwell Publishing Ltd, Molecular Microbiology, 81, 1034–1049licle substratum clearly visible, and an approximately
60% reduction in biomass. Bioﬁlms produced by strain
H360 after 24 h were also approximately 25 mm thick
with an ordered structure comprised of densely packed
cells (Fig. 7B). The H360 DaspA knockout mutant was
severely deﬁcient in bioﬁlm formation, with only small
clumps of cells adhering to the pellicle substratum and a
> 80% reduction in biomass (Fig. 7B). The comple-
mented mutants were fully restored in bioﬁlm formation,
in each case reaching similar levels of biomass to the
wild-type strains (Fig. 7). However, the architectures of
the complemented strain bioﬁlms were more disorga-
nized than wild-type strain bioﬁlms and the cells
appeared to be more loosely packed (Fig. 7). These
observations strongly suggest that AspA production is
essential for bioﬁlm formation by these two M28 sero-
type strains of GAS.
To further deﬁne the speciﬁcity of AspA in mediating
bioﬁlm formation, the abilities of DaspA and comple-
mented mutants to form bioﬁlms on gp-340, saliva or
polystyrene compared with wild-type strains were
investigated. Total biomass measurements for each wild-
type strain on the three substrata were not signiﬁcantly
different (Fig. 8). However, DaspA mutants of strains
MGAS6180 and H360 were signiﬁcantly impaired in
bioﬁlm formation on gp-340 compared with wild-type, with
60% reduced biomass (Fig. 8A and B). Likewise, DaspA
mutant bioﬁlms formed on 10% saliva-coated polystyrene
showed reduced biomass by approximately 50%. In con-
trast, there were no signiﬁcant differences in bioﬁlm pro-
duction on polystyrene between wild-type strains and their
respective DaspA mutants (Fig. 8A and B). The comple-
mented strains exhibited similar levels of bioﬁlm formation
(biomass) to wild-type strains on all three substrata tested
(Fig. 8). These results suggest AspA speciﬁcity for sali-
vary glycoprotein substratum.
AspA directly enhances bioﬁlm development
To conﬁrm that AspA plays a direct function in promoting
adherence and bioﬁlm formation, the effects of expressing
AspA in L. lactis on bioﬁlm formation were investigated.
Wild-type strain MG1363 cells produced a very sparse
bioﬁlm on salivary pellicle after 24 h incubation (Fig. 9A).
However, L. lactis (pKS80 aspA+) expressing AspA
protein produced a bioﬁlm approximately 26 mm thick of
densely packed cells (Fig. 9B), with more than threefold
higher biomass (Fig. 9D). We also compared the ability of
SspB protein to promote bioﬁlm formation in L. lactis.
Expression of SspB polypeptide led to a slight increase in
coverage of the substratum by L. lactis (pKS80 sspB +)
compared with wild-type L. lactis (Fig. 9C and D), but not
to the same extent as expression ofAspAdid (Fig. 9B and
D). This result may support the notion that AgI/II proteins
may be less intimately involved in bioﬁlm formation by
S. gordonii (Zhang et al., 2005). Collectively, the results
provide strong evidence that AspA is directly involved in
GAS bioﬁlm development upon salivary glycoprotein
substrata. In addition, while AspA appears to differ func-
tionally compared with some oral AgI/II-family polypep-
tides, it is suggested that AspA may constitute a novel
colonization factor in GAS.
Discussion
The AgI/II proteins have been a focus in studies of the
abilities of oral viridans streptococci to colonize oral cavity
and nasopharyngeal surfaces, and to cause tooth decay.
A primary host factor shown to be recognized by the
AgI/II-family proteins is the mucin-like glycoprotein desig-
nated salivary agglutinin (or gp-340). The signiﬁcance of
this interaction is believed to be at least double-edged:
Fig. 8. Bioﬁlm formation on gp-340, saliva and polystyrene by (A)
S. pyogenes MGAS6180 and (B) strain H360 (black ﬁll), and
corresponding isogenic DaspA mutants (no ﬁll) and complemented
strains DaspA (AspA+) (grey ﬁll). Biomass data were obtained by
crystal violet (A595) assay. Values given represent mean  SD of
three biological replicates from an experiment repeated twice.
**P < 0.01, *P < 0.05, relative to respective MGAS6180 or H360
wild-type strains.
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mucins, collectins and defensins, to restrict the growth of
commensal bacteria, while at the same time providing a
potential substratum for adhesion of bacteria to oral cavity
surfaces. Some oral streptococci, e.g. S. mutans, depend
strongly upon AgI/II protein for adherence, evidenced by
analyses of AgI/II gene knockout mutants that are ren-
dered deﬁcient in adherence to salivary glycoprotein pel-
licle (Koga et al., 1990). Other oral streptococci, such as
S. gordonii, appear to have evolved a wider repertoire of
salivary pellicle adhesins (Zhang et al., 2005), and so
AgI/II-deﬁcient mutants of these organisms may not be
noticeably affected in adherence (Jenkinson et al., 1993).
While the structural features and biological properties of
these proteins are to various degrees conserved, their
biological functions in respect of microbial physiology and
ecology may be quite different depending upon the
complement of adhesins that are expressed.
The overall structure of theAgI/II-family proteins may be
envisaged in terms of a head (V) region (Troffer-Charlier
et al., 2002), projected by a semi-ﬂexible stalk (formed by
interactionsoftheAandPregions)linkedtoawall-proximal
basal C-region (Brady et al., 2010). In the SspB protein
there is evidence that the head (V) and stalk (A–P)
regions provide gp-340-binding activity, and that the NAV
region functions in SspB-mediated co-aggregation with
A. naeslundii (Jakubovics et al., 2005). The C-terminal
region of SspB also has gp-340-binding activity, and
carriesasequence(designatedBAR)thatisrecognizedby
the periodontal disease-associated bacterium P. gingivalis
(Daep et al., 2008). The results in this article suggest that
the AspA N-terminal region does not interact in the same
way with ﬂuid-phase gp-340, although the C-terminal
region retains gp-340-binding sequences. These results
are somewhat different from those previously published
(Zhang et al., 2006), where it was shown that N-terminally
derived fragments of M28_Spy1325 bound ﬂuid-phase
gp-340.Onereasonforthisdiscrepancycouldberelatedto
the different gp-340 preparations being employed in the
two studies. In our study, gp-340 was puriﬁed from parotid
saliva, which contains no mucins, by adsorption to
S. mutans cells expressing AgI/II adhesin. However,
Zhang et al. (2006) utilized whole saliva (from several
glands) and adsorption to S. pyogenes cells expressing a
range of salivary glycoprotein adhesins. Secretory IgA is
known to be present in some gp-340 preparations and
could bind, complexed with gp-340, to AspA (Ligtenberg
et al., 2004). However, in the case of our gp-340 prepara-
tions,S-IgAisnotpresentatthelevelofchemicaldetection
(Loimaranta et al., 2005). Regardless of the reasons for
the discrepancy, the present data suggest a C-terminally
located AspA binding site for ﬂuid-phase gp-340, while
Zhang et al. (2006) indicate there may be multiple gp-340
binding sites in AspA.
The observation that the N-terminal region of AspA
does not apparently bind ﬂuid-phase gp-340 would be in
keeping with some of the features of the AspA primary
sequence that differ from those of SspB. The N-terminal
region of SpaP (and of SspB) has been shown to contain
a series of linear aa sequences that interact with salivary
Fig. 9. Confocal laser scanning microscopy
images and corresponding biomass
measurements of 24 h bioﬁlms formed on
salivary pellicle-coated coverslips of (A)
wild-type L. lactis MG1363; (B) L. lactis
(pKS80 aspA
+); and (C) L. lactis (pKS80
sspB
+). One unit is equivalent to the grid
square side length. Biomass results (D) were
obtained by crystal violet assay (A595)o f
corresponding bioﬁlms formed on coverslips.
The biomass data are averages  SD of
three independent experiments. **P < 0.005,
*P < 0.05, relative to L. lactis MG1363
wild-type.
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sequences are depicted as SGP1 and SGP2 in Fig. S1
and comprise SGP1 (TYEAALKQYEADL), repeated four
times with some conserved aa residue changes (Oka-
hashi et al., 1993), and SGP2 (TELARVQKANADA
KAAY), repeated three times with various conserved aa
residue changes (Moisset et al., 1994). In AspA, these
SGP-binding sequences are poorly conserved. The cor-
responding SGP1 sequences in AspA contain only
between two and ﬁve identical aa residues respectively
out of 13 within SspB (15–38%), while the SGP2
sequences inAspAcontain between two and ﬁve identical
aa residues out of 17 aa residues within SspB (12–29%).
Although L. lactis cells expressing AspA were not
enhanced in gp-340-mediated aggregation, they were
agglutinated by SRCRP2 peptide (Bikker et al., 2002),
conﬁrming that the two aggregation reactions occur by
different mechanisms.
On the other hand, the ADH1 and ADH2 sequences
identiﬁed by Kelly et al. (1995) within the C-terminal region
of SpaP that bind gp-340 are much better conserved in
AspA(Fig. S1). These sequences inAspAand SspB have
47–50% identical aa residues. Potentially therefore the
gp-340-binding regions within the C-terminus have been
relatively well conserved inAspA, and this is supported by
the far-Western blot data showing that the C-terminal
region of AspA binds gp-340.
The expression of aspA within the surrogate host
L. lactis showed clearly that the expressed protein medi-
ated adherence to immobilized gp-340, in a similar
manner to SspB. This appeared to be dependent upon the
VP region, since rVP-speciﬁc antibodies blocked adher-
ence to gp-340. Antibodies to the V region of SpaP have
also been shown to block adherence of S. mutans to
gp-340 (Brady et al., 1992). This ﬁnding indicates that the
V region of S. pyogenes AspA might be a target when
devising new means to inhibit colonization of mucosal
surfaces by S. pyogenes.
The SspA and SspB proteins in S. gordonii interact with
other bacteria and promote the formation of mixed
species communities. The N-terminal domains have been
shown to mediate co-aggregation of S. gordonii with
A. naeslundii in the formation of early microbial commu-
nities, with the V regions conferring strain speciﬁcity
(Jakubovics et al., 2005). We were unable to demonstrate
that L. lactis cells expressing AspA interacted with
A. naeslundii. This suggests that targeting of the V region
of S. pyogenes AspA in preventive strategies might not
affect development of oral bioﬁlm communities.
The differential interactions of AspA and SspB with
gp-340 could be related to the putative metal ion-binding
sites within the V regions. The V region of SspB has
recently been modelled with the structure resolved to
2.3 Å (Forsgren et al., 2009) to contain a Ca2+ molecule.
However, Mg2+ was shown to also ﬁt this model as an
alternative metal ion. Since Ca2+ and Mg2+ have a similar
charge and are of a similar size, and they were not dis-
tinguishable under the ICP-OES conditions used, they
could be interchangeable at this position. A main ﬁnding
was that AspA, but not SspB, bound one Zn2+ ion per
protein molecule. Binding of Zn2+ ions is often associated
with four aa residue ligands (His, Asp, Glu or Cys) (Vallee
andAuld, 1993; Auld, 2001).Aputative Zn2+ binding site is
found at 608–616 aa residues in AspA, and comprises
three His and three Asp residues (Fig. S1). In addition, a
number of potential, alternative ligand (His) aa residues
are located distally, between 20 and 129 aa residues
away from the metal ion-binding site, as is typical for Zn2+
binding protein domains (Andreini et al., 2006). None of
these potential Zn2+ binding residues is present within
SspB or within Enterococcus faecalis aggregation sub-
stance protein (Hendrickx et al., 2009), to which the V
region of AspA has 35–40% identity. Thus the N-terminal
region of AspA appears to have diverged such that it
contains at least one new metal ion (Zn2+) binding site.
The Zn2+ could have a structural or catalytic role. Histi-
dine residues are similarly positioned within Zn2+ binding
sequences in other streptococcal proteins such as
pneumococcal zinc metalloproteinase (Iga) (Bender
and Weiser, 2006) and metallopeptidase (Froeliger et al.,
1999). A gp-340-binding protein, designated StcE, identi-
ﬁed in enterohaemorrhagic E. coli has a histidine-rich Zn2+
binding site necessary for interaction and enzymatic
degradation of gp-340 (Lathem et al., 2002; Grys et al.,
2005). We have not been able to show that AspA has
proteolytic activity towards gp-340, under a wide range of
conditions. Nor has it been possible to demonstrate pro-
teolytic activity of rAspA on elastin, gelatin, collagen or
ﬁbrinogen (data not shown). We are currently investigat-
ing further the properties and functions of the V region in
AspA.
If bacteria in the oral cavity are rapidly aggregated by
gp-340 they may be cleared from the host before becom-
ing established within communities on the hard or soft
tissue or prosthetic surfaces available. Microorganisms
that are able to better evade innate defences such as
agglutination and phagocytosis will be able to colonize
and develop a niche that, in the case of GAS, may lead
to chronic infection. It is suggested that AspA on the
S. pyogenes cell surface binds to gp-340 present on oral
cavity or nasopharyngeal surfaces, as does SspB
expressed by S. gordonii, promoting colonization. The
SspB protein is then able to bind ﬂuid-phase gp-340,
promoting bioﬁlm formation through intermolecular brid-
ging of adhesins. AspA appears to promote bioﬁlm com-
munity formation, at least in part, through cell–cell
interactions mediated directly by AspA. Notably, AspA
polypeptide expression was necessary for bioﬁlm forma-
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plastic (polystyrene), but not for bioﬁlm formation on the
plastic itself. This suggests that the bacteria respond to
the physiological substratum (salivary glycoproteins). The
mechanism by which this might occur is currently not
known, but aspA could be upregulated in response to
salivary glycoproteins, which would be in keeping with
evidence that the S. gordonii sspA and sspB genes are
upregulated in response to saliva (Dû and Kolenbrander,
2000).
The reduced ability of AspA to bind ﬂuid-phase gp-340
could suggest that GAS cells are less likely to be subject
to innate defence recognition. Since scavenger receptor-
like (SRCR) sequences are also expressed on the sur-
faces of macrophages and of other immune cells (Sarrias
et al., 2004), it could be that reduced binding to various
forms of these receptors may further enable GAS to more
effectively evade immune defences. This possibility is cur-
rently under investigation. In conclusion it is suggested
that AspA provides S. pyogenes with a new salivary pel-
licle or mucosal surface adhesin that increases GAS com-
petitiveness with indigenous or commensal microbiota to
generate a niche. Although the pilus structures in GAS
serotype M1 strain S370 have been shown to be neces-
sary for bioﬁlm formation (Manetti et al., 2007), pili do not
appear to be essential for bioﬁlm development by the two
M28 strains used in this work. DirectAspAprotein–protein
interactions are probably responsible for enhanced bioﬁlm
formation and GAS community development. This could
provide increased protection in vivo against killing by anti-
biotics or advance pathogenicity by protecting against
phagocytic cells. Taken collectively, these studies identify
AspA as a potential new colonization factor in GAS sero-
type M28 and other aspA-carrying strains that could be a
novel target for intervention.
Experimental procedures
Bacterial strains
Strains used in this study are outlined in Table S1. E. coli
strains JM109 and XL1 were used for molecular cloning
experiments to generate pET vector- or pGEM-T-based con-
structs, and E. coli BL21/lDE3 (Novagen) for expressing
recombinant proteins. E. coli was cultured in LB broth at 37°C
with shaking. Streptococcus strains were grown in Todd–
Hewitt broth (Oxoid) containing 0.5% yeast extract. Actinomy-
ces strains were grown in TY-glucose medium (Jakubovics
et al., 2005). S. pyogenes strains were cultured at 37°C in an
atmosphere of 5% CO2 while all other Streptococcus and
Actinomyces strains were grown in a candle jar at 37°C.
L. lactis strains were routinely cultured in M17 medium con-
taining0.5%glucoseinacandlejarat30°C.Bactoagar(Difco)
was added at 1.4% ﬁnal concentration as appropriate. For
analysis of aggregation properties, L. lactis strains were
grown in C medium containing 0.2% glucose (Lyon et al.,
1998). Antibiotics were added to media at the following con-
centrations:ampicillin,100 mgm l
-1andkanamycin,50 mgm l
-1
for E. coli; erythromycin, 10 mgm l
-1 for L. lactis; spectinomy-
cin, 100 mgm l
-1 and erythromycin, 5 mgm l
-1 for S. pyogenes.
Recombinant protein production and puriﬁcation
Chromosomal DNA was extracted from S. pyogenes
MGAS6180 as described previously (Jenkinson, 1987).
Primers (Sigma Aldrich) were designed to amplify regions of
the locus spy1325 (aspA) corresponding to the full-length
AspA protein excluding the leader sequence and cell wall
anchor motif (AspA-F1 & AspA-R1), NAV region (AspA-F1 &
AspA-R3), VP region (AspA-mF & AspA-mR) and C region
(AspA-F3 & AspA-R1) of AspA (Table S2; Fig. S1). Additional
sequence was incorporated at the 5′ end of both the forward
(gacgacgacaagatx) and reverse primers (gaggagaagcccg
gtxx), to enable the PCR products to be cloned into
the ligation-independent expression vector pET46-Ek-LIC
(Novagen). PCR utilized a proofreading enzyme (Bio-X-Act
Long; Bioline) and the PCR products were treated with T4
polymerase (Novagen) prior to mixing with pET46, according
to the manufacturer’s instructions. Fragments cloned into
pET46 incorporated a sequence encoding a 6x His-tag at the
N-terminus of the polypeptide.
Expression vectors were transformed into chemically-
induced competent E. coli BL21/lDE3 (Novagen), prepared
by the method of Hanahan (1983). Cells were grown with
vigorous shaking at 37°C and protein expression was
induced with IPTG (1 mM). Induced cultures were incubated
at 30°C until early stationary phase and cells were lysed
using Bugbuster (Novagen). Recombinant proteins were
puriﬁed using immobilized metal ion affinity chromatography
on IMAC Sepharose
TM 6 Fast Flow (GE Healthcare). The
imino-diacetic acid ligand was charged with 0.5 M
NiSO4·6H2O and equilibrated with 50 mM HEPES (pH 7.4)
containing 0.5 M NaCl, 10% glycerol, 0.1% Triton X-100
and 5 mM imidazole. Recombinant protein fragments were
eluted using 150 mM imidazole in the same buffer and pro-
teins were resolved by SDS-PAGE with 8% acrylamide.
Full-length SspB was puriﬁed from inclusion bodies that
were prepared using Bugbuster (Novagen) according to the
manufacturer’s instructions. Inclusion bodies were dissolved
in 8 M urea supplemented with 0.1% Sarkosyl, then diluted
to 3.4 M urea in 50 mM HEPES buffer (pH 7.4) containing
0.1% Sarkosyl. Recombinant SspB was refolded in situ on
the IMAC column by washing with 50 mM HEPES (pH 7.4)
containing 0.1% Sarkosyl, followed by further washes with
50 mM HEPES (pH 7.4) containing 0.1% Triton X-100 and
5 mM imidazole. SspB was eluted in 50 mM HEPES (pH
7.4), 0.1% Triton X-100 and 150 mM imidazole.
Metal ion analysis
Recombinant protein fragments of AspA and SspB
(100 ng ml
-1 in 50 mM HEPES, pH 7.4 containing 0.5 M NaCl,
10% glycerol and 0.1% Triton X-100) were analysed by ICP-
OES (Perkin-Elmer Optima 3000). Calibration used the ICP
multi-element standard solution IV (Merck) containing 23 ele-
ments (Ag, Al, B, Ba, Bi, Ca, Cd, Co, Cr, Cu, Fe, Ga, In, K, Li,
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preparation was assayed for the presence of Cu, Fe, Mn, Mg,
Ni and Zn, the concentrations of which were calculated as
molar ratios and normalized for the buffer alone.
Cell surface protein extraction and Western blotting
Proteins were extracted from the surface of S. pyogenes cells
by modiﬁcation of the method utilized to extract surface pro-
teins from S. gordonii and L. lactis (Jakubovics et al., 2005).
The modiﬁcation involved incubating cells suspended in
spheroplasting buffer with mutanolysin (500 U) and lysozyme
(3 mg ml
-1) for 2 h at 37°C. Proteins were solubilized in SDS-
containing buffer without 2-mercaptoethanol and separated
by SDS-PAGE. Polypeptides were transferred onto nitro-
cellulose membrane by Western electroblotting. Blots
were blocked with 1% bovine serum albumin (BSA) or 1%
skimmed milk powder in Tris-buffered saline supplemented
with 0.1% Tween 20 (TTBS) and then incubated with primary
antibody at appropriate dilution. Antibody binding was
detected with HRP-linked goat anti-rabbit IgG, and blots were
developed using 4-chloro-1-naphthol or by ECL (Amersham).
Antibodies to AspA-VP were raised in New Zealand White
rabbits (Covalab) and anti-SpaP rabbit antibodies were kindly
provided by Charles Kelly (Kings College London). Both anti-
sera were routinely used at 1:1000 dilution.
In vitro gp-340 binding assays
Gp-340 was prepared from parotid saliva samples pooled
from multiple donors using a multi-step procedure including
adsorption onto S. mutans as described previously (Loima-
ranta et al., 2005). Adherence of L. lactis cells expressing
AspA or SspB to immobilized gp-340 was carried out by
crystal violet assay and data converted to cell numbers as
previously described (Jakubovics et al., 2005). Immulon 2HB
96-well microtitre plates were coated with 50 ng gp-340 in
coating buffer (20 mM Na2CO3, 20 mM NaHCO3; pH 9.3) as
this gp-340 concentration was found to be optimal for the
assay. For antibody inhibition studies, L. lactis cells express-
ing AspA, or L. lactis MG1363 controls, were incubated with
dilutions of various antisera for 30 min at 25°C before being
assayed directly for binding to immobilized gp-340. Absor-
bance values were corrected against those obtained with
corresponding L. lactis control cells taken through the entire
procedure.
Transformation of L. lactis MG1363
Plasmid pKS80 expressing SspB (pKS80 sspB
+) was pro-
duced by PCR (Expand Long PCR, Roche) of sspB
(GenBank Accession No. U40027) using primer pairs
BamH1F & BamH1Rev and BamSspF2 & BamH1Rev
(Table S2) to remove the internal BamHI site. The sspB frag-
ment was subcloned into pKS80 using BamHI and SbfI.
Plasmid pKS80 aspA
+ was produced by PCR ampliﬁcation of
the 4.5 kb region corresponding to aspA from S. pyogenes
H360 (which shares 100% identity with spy1325/aspA from
MGAS6180) using primers AgI/II-pKSF and AgI/II-pKSR
(Table S1), and subcloning into pKS80 using BamHI and PstI.
Electrocompetent cells of L. lactis were prepared by cultur-
ing in GM17G broth (M17 broth supplemented with 10%
glycine and 0.5% glucose) at 30°C to OD600 = 0.5–0.6. Cul-
tures were incubated on ice for 10 min and cells harvested by
centrifugation (3000 g, 4°C, 10 min). Cells were suspended
in electroporation buffer (0.5 M glucose, 10% glycerol) and
electroporated using a Bio-Rad Genepulser II at 1 kV voltage,
50 mF capacitance and 100 W resistance. Transformants
were recovered in modiﬁed M17 medium (M17 containing
0.5% glucose, 0.5 M sucrose, 20 mM MgCl2 and 2 mM
CaCl2), plated onto M17 agar supplemented with appropriate
antibiotics, and incubated for up to 48 h at 30°C in a candle
jar. Expression of SspB or AspA on the surface of L. lactis
was veriﬁed by SDS-PAGE and Western immunoblot
analyses. Expression levels of SspB and AspA were similar
as visualized on Coomassie blue-stained gels.
Far-Western analysis of gp-340 binding to recombinant
AspA protein fragments
Proteins were transferred from SDS-PAGE gels to PVDF
membrane by electroblotting at 50 V for 2 h. Membranes
were blocked for 16 h in Tris-buffered saline containing 0.1%
Tween 20 and 1% BSA (TTBS-BSA). The membrane was
incubated at 20°C for 1 h in TTBS-BSA containing 0.5 mgo f
puriﬁed gp-340 (Loimaranta et al., 2005) and washed twice
with TTBS. Mouse monoclonal primary anti-gp-340 antibody
(BioPorto Diagnostics, Denmark) in TTBS-BSA was incu-
bated with the membrane for 1 h at 20°C and the membrane
washed as before. Antibody binding was detected using
HRP-conjugated goat polyclonal anti-mouse antibody (Dako-
Cytomation) and blots were developed with 4-chloro-1-
naphthol. The monoclonal primary anti-gp-340 antibody or
secondary antibody did not react directly with the AgI/II
protein bands.
Gp-340- or peptide SRCRP2-mediated aggregation
assays
Lactococcus lactis strains were grown in C medium and
harvested by centrifugation at 5000 g for 10 min. The OD600
was adjusted to 0.6, and aggregation assays were carried out
in triplicate as previously described (Jakubovics et al., 2005).
Gp-340 or SRCRP2 (16-mer peptide; QGRVEVLYRG-
SWGTVC) in PBS were added to cell suspensions (ﬁnal
concentration 0.5 mgm l
-1). These were incubated at 37°C
and OD600 readings taken at regular intervals over a period of
5 h. Controls containing no gp-340 or SRCRP2 were analy-
sed simultaneously. Aggregation was expressed as a per-
centage decrease in OD600 relative to 100% aggregation.
Generation of aspA knockout mutants
Knockout mutants of strains H360 and MGAS6180 were gen-
erated through allelic replacement of aspA with aad9 (encod-
ing spectinomycin resistance), and were complemented in
trans with pKS80 aspA
+ plasmid. The mechanism for gener-
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MGAS6180 sequence. A 1045 bp region directly upstream
of aspA and a 1051 bp region directly downstream were
ampliﬁed using primers US1325-F & US1325-R, DS1325-F &
DS1325-R respectively, which introduced BamHI sites into
the products (Table S2). These fragments were stitched
together in a second round of PCR using primers US1325-F
& DS1325-R (Table S2) that generated a 2 kb fragment with
a central BamHI site. This PCR product was ligated into
pGEM-T (Promega), generating pGEM-T::aspA-2kb, and this
plasmid was transformed into E. coli XL1. The aad9 gene,
encoding spectinomycin resistance, was PCR-ampliﬁed
using primers Aad9fwd & Aad9rev (Table S2) and then sub-
cloned into pGEM-T::aspA-2kb at the BamHI site, thus inter-
rupting the truncated aspA fragment and providing a means
of positive selection of transformants (Fig. S2A). The result-
ing plasmid construct, designated pGEM-T::aspA-aad9, was
transformed into GAS by electroporation as described above.
Transformants were recovered on THY agar supplemented
with spectinomycin at 37°C in 5% CO2 for up to 48 h. Correct
insertions were identiﬁed by PCR of chromosomal DNA with
primers US1325-F & DS1325-R, and the products were
sequenced to conﬁrm authenticity.
Saliva collection
Whole saliva was collected from ﬁve to eight healthy
volunteers. Following collection, saliva was pooled and
dithiothreitol added to a ﬁnal concentration of 2.5 mM. Par-
ticulate matter and mucins were removed by centrifugation at
13 000 g for 10 min. Clariﬁed saliva was diluted to 10% con-
centration with distilled water, passed through a 0.2 mm nitro-
cellulose ﬁlter and stored at -20°C. Local guidelines for
collection, storage and disposal were followed in accordance
with the Human Tissue Act.
Static bioﬁlm models
Strains were initially grown in C medium for 16 h in 5% CO2,
cells were harvested by centrifugation, and suspensions
adjusted to OD600 = 0.1 in modiﬁed C medium (0.25% Difco
Proteose Peptone #2, 0.75% yeast extract, 10 mM K2HPO4,
0.4 mM MgSO4, 17 mM NaCl, pH 7.5) containing 0.2%
glucose. Bioﬁlms were grown on sterile 13-mm-diameter
glass coverslips (Menzel-Glaser, Germany) that had been
incubated with 0.5 ml of 10% saliva (4°C for 16 h) in 24-well
microtitre plates (Greiner). Cell suspensions (0.5 ml) were
added to wells containing saliva-coated coverslips and incu-
bated at 37°C under 5% CO2 for 24 h. To estimate biomass,
bioﬁlms on glass coverslips were washed twice with PBS and
stained with crystal violet for 10 min. After washing with dis-
tilled water the bioﬁlm-coated coverslips were transferred to a
fresh 24-well plate, crystal violet was solubilized with 7%
acetic acid, and absorbance at 595 nm (A595) measured as an
indicator of biomass (Jakubovics et al., 2005).
In separate experiments to compare bioﬁlm formation on
different substrata, gp-340 (50 ng) or saliva (10%) was
adsorbed onto the surface of Immulon 2HB 96-well microtitre
plates. Non-speciﬁc binding sites were blocked with 3% BSA
and the wells washed in TBS. S. pyogenes strains were
grown in C medium for 16 h at 37°C in 5% CO2, harvested by
centrifugation, and cell suspensions adjusted to OD600 = 1.0
in modiﬁed C medium containing 0.2% glucose. Suspensions
(0.1 ml) were applied to triplicate wells and incubated for 3 h
at 37°C in 5% CO2. Suspensions were then aspirated and the
wells washed in TBS before fresh modiﬁed C medium/0.2%
glucose (0.2 ml) was added to each well. Plates were incu-
bated for a further 20 h, after which time wells were washed
with TBS and the bioﬁlms stained with 0.5% crystal violet for
2 min. Excess stain was removed by washing in TBS, remain-
ing crystal violet solubilized in 10% acetic acid (0.1 ml), and
A595 values were determined as before.
Confocal microscopy
Mature 24 h bioﬁlms, grown as described above, were
washed with PBS and ﬁxed with 0.5 ml of 4% paraformalde-
hyde for 1 h at room temperature. Bioﬁlm-coated coverslips
were washed with PBS prior to staining with ﬂuorescein
isothiocyanate (FITC; 1.5 mM ﬁnal concentration in 0.05 M
Na2CO3 containing 0.1 M NaCl) for 1 h with gentle agitation in
the dark. Washed bioﬁlm-coated coverslips were mounted
onto microscope slides in 5 ml of Vectashield mounting
medium containing DAPI (Vectorlabs) and sealed onto the
slide with varnish. Bioﬁlms were visualized using a Leica
TCS-SP2 confocal imaging system attached to a Leica
DMIRBE inverted microscope. Analysis of the data was
carried out using Volocity image analysis software
(Improvision).
Statistical analysis
All data are reported as mean  standard deviation (SD)
unless otherwise indicated. Signiﬁcance between samples
was determined using the paired two-tailed Student’s t-test,
and a value of P < 0.05 was accepted as indicating signiﬁ-
cance.DatawereanalysedwithGraphPadPrismv5software.
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